 |
 |
Product ID |
Structure |
Product Name |
Purity |
Price(s) |
Delete |
D642028 |
 |
(1R,2R)-2-phenylcyclopropanamine;hydrochloride |
97%
|
$190/100mg, $250/250MG, $400/500MG, $605/1G |
 |
Y1231984 |
 |
(1S,2S)-2-phenylcyclopropanamine;hydrochloride |
97%
|
$435/100mg, $695/250MG, $1155/500MG, $1735/1G, $5215/5G |
 |
Y4003254 |
 |
[2-hydroxy-6-(trifluoromethoxy)phenyl]boronic acid |
97%
|
$225/100mg, $275/250mg, $310/500mg, $415/1g |
 |
D747044 |
 |
1-(2-Hydroxynaphthalen-1-yl)ethanone |
97%
|
$50/250mg, $55/1g, $55/5g, $65/10g, $85/25g, $175/100g, $630/500g |
 |
Y3268049 |
 |
1H-indole-3-sulfonamide |
95%
|
$175/50mg, $230/100mg, $365/250mg, $965/1g |
 |
D747829 |
 |
2,2-BIS(4-OXOCYCLOHEXYL)PROPANE |
95.0%
|
$85/1g, $170/5g |
 |
Y3150908 |
 |
3-BENZYLSULFONYLPYRROLIDINE HYDROCHLORIDE |
95%
|
$275/50mg, $395/100mg, $550/250mg, $860/500mg, $1105/1g |
 |
D754292 |
 |
3-ethyl-1-[2-methyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea |
95%
|
$270/250mg, $530/1g |
 |
Y3158700 |
 |
4-methanesulfonyl-2,3-dihydro-1H-indole, trifluoroacetic acid |
95%
|
$410/50mg, $595/100mg, $850/250mg, $1335/500mg, $1710/1g |
 |
Y3101470 |
 |
4-tert-butyl-1,2,3,4-tetrahydroquinoxalin-2-one |
95%
|
$305/50mg, $450/100mg, $625/250mg, $975/500mg, $1250/1g |
 |
Y3152101 |
 |
5-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]oxolane-3-carboxylic acid |
95%
|
$530/50mg, $790/100mg, $1125/250mg, $1765/500mg, $2265/1g |
 |
D619149 |
 |
5-chloro-1-[trans-3-fluoro-1-(oxetan-3-yl)piperidin-4-yl]-1H-pyrazol-4-amine |
97%
|
$415/100MG, $835/250MG, $1395/500MG, $2095/1G, $6285/5G, $10475/10G |
 |
Y3312542 |
 |
8α-Hydroxyhirsutinolide |
98.0%
|
$935/5mg |
 |
Y3243755 |
 |
Benzoic acid, 3-chloro-4,5-dimethoxy- |
95%
|
$120/100mg, $140/250mg, $150/500mg, $185/1g, $415/5g |
 |
Y1219140 |
 |
tert-butyl (1S)-1-(hydroxymethyl)-2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate |
97%
|
$335/100mg, $540/250MG,$900/500MG,$1350/1G,$4050/5G |
 |
Y3288167 |
 |
tert-butyl N-({1-amino-3-oxaspiro[bicyclo[2.1.1]hexane-2,1'-cyclobutane]-4-yl}methyl)carbamate |
95%
|
|
 |
|
|
|
 |
 |
 |